Gly-β-MCA

Overview

Gly-β-MCA, a bile acid, is a potent, sable, intestine-selective and oral bioactive farnesoid X receptor ( FXR ) inhibitor that may be a candidate for the treatment of metabolic disorders.

Application

Products | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Obesity | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Lipid Metabolism | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Autophagy | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > FXR | Products > Signaling Pathways > Autophagy

Product Information

• Catalog No.: HY-114392
• CAS No.: 66225-78-3
• Molecular Formula: C26H43NO6
• Molecular Weight: 465.62
• Purity: 99.75%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.08 mg/mL (4.47 mM); Clear solution
• Availability: In-stock

Source

Original product source